- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/215 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
Patent holdings for IPC class A61K 31/215
Total number of patents in this class: 1280
10-year publication summary
|
94
|
111
|
106
|
80
|
88
|
84
|
72
|
61
|
58
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20473 |
18 |
| Allergan, Inc. | 2225 |
13 |
| Infirst Healthcare Limited | 60 |
12 |
| Mati Therapeutics Inc. | 61 |
10 |
| RespiVert Ltd. | 79 |
10 |
| University of Washington | 2398 |
10 |
| Arbor Pharmaceuticals, LLC | 66 |
9 |
| BioCryst Pharmaceuticals, Inc. | 179 |
9 |
| Nabriva Therapeutics GmbH | 15 |
9 |
| Hong Kong King-friend Industrial Company Ltd. | 41 |
9 |
| Biosuccess Biotech Co. Ltd. | 25 |
8 |
| CEVA Sante Animale | 710 |
8 |
| Versitech Limited | 371 |
8 |
| Aker Biomarine Human Ingredients AS | 104 |
8 |
| Board of Regents, The University of Texas System | 6018 |
7 |
| Epicentrx, Inc. | 84 |
7 |
| MedImmune, LLC | 499 |
7 |
| N.V. Nutricia | 1082 |
7 |
| Boehringer Ingelheim Animal Health USA Inc. | 418 |
7 |
| Novartis AG | 10376 |
6 |
| Other owners | 1098 |